Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$37.32 - $49.29 $4,627 - $6,111
-124 Reduced 1.5%
8,156 $307,000
Q2 2023

Aug 08, 2023

BUY
$39.98 - $47.68 $3,798 - $4,529
95 Added 1.16%
8,280 $377,000
Q1 2023

May 05, 2023

BUY
$37.58 - $52.57 $92,709 - $129,690
2,467 Added 43.14%
8,185 $331,000
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $284,184 - $329,985
5,718 New
5,718 $291,000
Q2 2022

Aug 03, 2022

BUY
$63.83 - $80.0 $21,766 - $27,280
341 Added 10.64%
3,547 $228,000
Q1 2022

May 05, 2022

SELL
$76.85 - $89.45 $224,555 - $261,372
-2,922 Reduced 47.68%
3,206 $231,000
Q4 2021

Feb 08, 2022

BUY
$74.57 - $87.19 $13,795 - $16,130
185 Added 3.11%
6,128 $526,000
Q3 2021

Nov 04, 2021

BUY
$73.77 - $83.61 $15,713 - $17,808
213 Added 3.72%
5,943 $478,000
Q2 2021

Aug 04, 2021

BUY
$80.5 - $88.01 $5,554 - $6,072
69 Added 1.22%
5,730 $461,000
Q1 2021

May 11, 2021

BUY
$76.38 - $86.03 $4,048 - $4,559
53 Added 0.95%
5,661 $477,000
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $3,995 - $4,365
-53 Reduced 0.94%
5,608 $450,000
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $18,015 - $20,867
230 Added 4.23%
5,661 $455,000
Q2 2020

Jul 31, 2020

SELL
$78.66 - $94.14 $235 - $282
-3 Reduced 0.06%
5,431 $468,000
Q1 2020

May 06, 2020

BUY
$71.57 - $93.3 $388,911 - $506,992
5,434 New
5,434 $441,000
Q4 2019

Feb 13, 2020

SELL
$76.7 - $88.45 $232,784 - $268,445
-3,035 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$81.4 - $89.78 $7,570 - $8,349
-93 Reduced 2.97%
3,035 $265,000
Q2 2019

Aug 07, 2019

BUY
$73.44 - $82.41 $6,168 - $6,922
84 Added 2.76%
3,128 $256,000
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $1,612 - $2,032
-25 Reduced 0.81%
3,044 $0
Q4 2018

Feb 08, 2019

BUY
$61.45 - $77.8 $6,452 - $8,169
105 Added 3.54%
3,069 $202,000
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $209,584 - $230,451
2,964 New
2,964 $228,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.